The HRCR-group is doing research in the fields of Resuscitation and in the field of Cardiology. In both of these fields are we exploring how different drug treatment options can be optimized to improve clinical outcome.
At the moment we have three PhD projects ongoing:
1. Which are the physiologic effects of adrenaline (epinephrine) during cardiopulmonary resuscitation?
2. The use of flecainide for treatment of atrial fibrillation, an evaluation of a structured program at Skånes hospital northwest and Skånes university hospital.
3. Adrenaline (epinephrine) dosing effects during CPR and and its relation to neurological outcome following cardac arrest.
And two medical student project ongoing:
1. A comparative study on approaches to ECMO in cardiac arrest
2. What impact do the new cholesterol-lowering drug guidelines have on the treatment strategy for patients with acute
coronary syndrome and how is this related to the cost benefit of the global risk reduction strategy?
And one Nursing project:
1. New onset Atrial fibrillation. An evaluation of the introduction of a "fast track" for patients who seek care at the emergency department with new onset of atrial fibrillation (Anette Asp)
The HRCR- group, is a University research group that works with research in the field of cardio- pulmonary resuscitation but also in other cardiac health care related research (atrial fibrillation/flutter). The overall objectives for the initial projects are to evaluate the effects of drugs and organizational structures of treatments given in these two areas. The aim is to improve the treatment and outcomes for patients by means of more effective use of available drugs and to optimized care.